Nuvalent Inc (NUVL) USD0.0001 A
Sell:$73.16Buy:$73.32
$1.65 (2.30%)
- This stock can be held in a
Stocks and Shares ISASell:$73.16
Buy:$73.32
Change:$1.65 (2.30%)
$1.65 (2.30%)Prices delayed by at least 15 minutes
Sell:$73.16
Buy:$73.32
Change:$1.65 (2.30%)
$1.65 (2.30%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 13 May 2024 | Matthew D. (Matt) ShairOther Level A | Sell Regular sell transaction (market) | 19,909 | $65.42 | $1,302,446.78 | 1,442,289 |
| 13 May 2024 | Matthew D. (Matt) ShairOther Level A | Sell Regular sell transaction (market) | 13,129 | $66.12 | $868,089.48 | 1,429,160 |
| 13 May 2024 | Matthew D. (Matt) ShairOther Level A | Sell Regular sell transaction (market) | 4,462 | $66.86 | $298,329.32 | 1,424,698 |
| 6 May 2024 | Matthew D. (Matt) ShairOther Level A | Sell Regular sell transaction (market) | 29,600 | $69.27 | $2,050,392.00 | 1,470,098 |
| 6 May 2024 | Matthew D. (Matt) ShairOther Level A | Sell Regular sell transaction (market) | 7,900 | $70.27 | $555,133.00 | 1,462,198 |
| 2 May 2024 | Deborah Ann (Deb) MillerChief Legal/Compliance Officer | Sell Option/Award related | 1,566 | $71.55 | $112,047.30 | 34,734 |
| 2 May 2024 | Deborah Ann (Deb) MillerChief Legal/Compliance Officer | Sell Option/Award related | 1,296 | $72.58 | $94,063.68 | 33,438 |
| 2 May 2024 | Deborah Ann (Deb) MillerChief Legal/Compliance Officer | Sell Option/Award related | 138 | $73.13 | $10,091.94 | 33,300 |
| 29 April 2024 | Matthew D. (Matt) ShairOther Level A | Sell Regular sell transaction (market) | 15,693 | $67.01 | $1,051,587.93 | 1,521,505 |
| 29 April 2024 | Matthew D. (Matt) ShairOther Level A | Sell Regular sell transaction (market) | 20,207 | $67.81 | $1,370,236.67 | 1,501,298 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 27 March 2024 | BAIN CAPITAL LIFE SCIENCES INVESTORS LLCHedge Fund | Sell Regular sell transaction (market) | 791,795 | $72.31 | $57,254,696.45 | 2,697,267 |
| 27 March 2024 | BAIN CAPITAL LIFE SCIENCES INVESTORS LLCHedge Fund | Sell Regular sell transaction (market) | 88,205 | $76.88 | $6,781,262.14 | 3,489,062 |
| 26 December 2023 | Matthew D. (Matt) ShairOther Level A | Sell Regular sell transaction (market) | 68,665 | $75.13 | $5,158,801.45 | 1,774,246 |
| 24 October 2023 | Matthew D. (Matt) ShairOther Level A | Sell Regular sell transaction (market) | 81,531 | $50.63 | $4,127,914.53 | 1,863,167 |
| 18 December 2023 | Darlene NociChief Level Officer | Sell Option/Award related | 40,000 | $75.82 | $3,032,800.00 | 0 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.